Mahmoud A Ghannoum
Mahmoud A Ghannoum is an expert in Infectiology at University Hospitals of Cleveland (United States). As of October 2026, ScienceLeadR ranks Mahmoud A Ghannoum in the top 1% of experts worldwide for Mycoses. Mahmoud A Ghannoum has authored 494 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,881 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Dermatology - Nutrition - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1988 - 2026
Number : 494
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| In Vitro Terbinafine Susceptibility of Dermatophytes and Mycological Cure Outcomes from a Multicenter Phase III Onychomycosis Trial. PMID 42930704 — terbinafine, onychomycosis, arthrodermataceae | J Fungi (Basel) | 2026 | 0 |
| A chloramine-based antiseptic polymer improves Candida auris skin decolonization compared to chlorhexidine in a murine model. PMID 42627266 — skin, polymers, anti-infective agents, local, ear, chlorhexidine, drug therapy, centers for disease control and prevention, u.s., anti-bacterial agents, candida, antiviral agents | Antimicrob Agents Chemother | 2026 | 0 |
| Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation. PMID 42280437 — toll-like receptors, glucans, cells, cell wall, neoplasms, receptors, complement, food, immunity, therapeutics, infections | Nutrients | 2026 | 3 |
| Antifungal efficacy of a novel nitric oxide releasing solution in the presence of keratin. PMID 42131304 — terbinafine, onychomycosis, solutions, cell biology, therapeutics, keratins | Front Cell Infect Microbiol | 2026 | 0 |
| Improving Growth Dynamics of Faecalibacterium prausnitzii by Exposure to Prebiotics. PMID 41751835 — oligosaccharides, bile, starch, growth, immunomodulation, faecalibacterium, resistant starch, pectins, prebiotics, probiotics, faecalibacterium prausnitzii, inulin, riboflavin | Int J Mol Sci | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map